Thyroid-related ophthalmopathy (TRO) or thyroid eye disease (TED) occurs in up to 50% of patients with systemic Graves hyperthyroidism as well as a smaller percentage of patients with other autoimmune thyroid disorders such as Hashimoto thyroiditis. Some of the underlying immunological mechanisms have been studied and elucidated, including stimulatory pathways that lead to orbital fibroblast proliferation, fat hypertrophy, and extraocular muscle changes.
Date
2020-03
Language
eng
Format
video/mp4
Type
Image/MovingImage
Source
2020 North American Neuro-Ophthalmology Society Annual Meeting
Relation is Part of
NANOS Annual Meeting 2020: New Treatments in Neuro-Ophthalmology-2020 Trends